2. Academic Validation
  3. Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells

Pharmacologic inhibition of ATR and ATM offers clinically important distinctions to enhancing platinum or radiation response in ovarian, endometrial, and cervical cancer cells

  • Gynecol Oncol. 2015 Mar;136(3):554-61. doi: 10.1016/j.ygyno.2014.12.035.
Pang-ning Teng 1,  Nicholas W Bateman 1,  Kathleen M Darcy 1,  Chad A Hamilton 2,  George Larry Maxwell 3,  Christopher J Bakkenist 4,  Thomas P Conrads 5
Affiliations

Affiliations

  • 1 Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA.
  • 2 Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA; Gynecologic Oncology Service, Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
  • 3 Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA; Department of Obstetrics and Gynecology, Inova Fairfax Hospital, Fairfax, VA, USA.
  • 4 Department of Radiation Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA; Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA.
  • 5 Women's Health Integrated Research Center at Inova Health System, Department of Defense Gynecologic Cancer Center of Excellence, Annandale, VA 22003, USA. Electronic address: conrads@whirc.org.
PMID: 25560806 DOI: 10.1016/j.ygyno.2014.12.035
Abstract

Objective: Significant reductions in gynecologic (GYN) Cancer mortality and morbidity require treatments that prevent and reverse resistance to chemotherapy and radiation. The objective of this study was to determine if pharmacologic inhibition of key DNA damage response kinases in GYN cancers would enhance cell killing by platinum-based chemotherapy and radiation.

Methods: A panel of human ovarian, endometrial and cervical Cancer cell lines were treated with platinum drugs or ionizing radiation (IR) along with small molecule pharmacological kinase inhibitors of Ataxia telangiectasia mutated (ATM) and ATM and Rad-3-related (ATR).

Results: Pharmacologic inhibition of ATR significantly enhanced platinum drug response in all GYN Cancer cell lines tested, whereas inhibition of ATM did not enhance the response to platinum drugs. Co-inhibition of ATM and ATR did not enhance platinum kill beyond that observed by inhibition of ATR alone. By contrast, inhibiting either ATR or ATM enhanced the response to IR in all GYN Cancer cells, with further enhancement achieved with co-inhibition.

Conclusions: These studies highlight actionable mechanisms operative in GYN Cancer cells with potential to maximize response of platinum agents and radiation in newly diagnosed as well as recurrent gynecologic cancers.

Keywords

ATM; ATR; Cisplatin resistance; DNA damage repair response; Gynecologic cancer; Ionizing radiation.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z